20.11.2012
- New Markets - An estimated 25 million people in the U.S. suffer from rare diseases, known in the pharmaceutical industry as "orphan diseases". While the prevalence of each...
01.11.2012
- Medical journal The Lancet warned that Sanofi's experimental multiple sclerosis drug Lemtrada may be too costly for patients and health insurers once it gets approved by regulators...
